Current NIH-funded bench research programs are focused on neurodevelopment and neonatal neuroprotection. We use a variety of animal models, from rodents to non-human primates to determine the effects of neonatal stress and neurotropic drugs on the developing brain, and to test the safety and efficacy of erythropoietin (Epo) as a neuroprotective therapy. Clinical research is focused on clinical trials of Epo in preterm and asphyxiated infants, prevention of BPD, biomedical informatics, medical education including the use of newborn infant simulators, Global Health, and epidemiologic research.
For more information on this specialty, please visit the Neonatology webpage.